MARKET

OVIT

OVIT

Oncovista Innovative Therapies
EXMKT
0.0001
NaN%
Closed 09:30 03/06 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0001
52 WEEK LOW
0.0001
MARKET CAP
2.36K
P/E (TTM)
-0.0007
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OVIT last week (0908-0912)?
Weekly Report · 09/15/2025 11:54
Weekly Report: what happened at OVIT last week (0901-0905)?
Weekly Report · 09/08/2025 11:56
Weekly Report: what happened at OVIT last week (0825-0829)?
Weekly Report · 09/01/2025 11:50
Weekly Report: what happened at OVIT last week (0818-0822)?
Weekly Report · 08/25/2025 12:04
Weekly Report: what happened at OVIT last week (0811-0815)?
Weekly Report · 08/18/2025 11:54
Weekly Report: what happened at OVIT last week (0804-0808)?
Weekly Report · 08/11/2025 12:04
Weekly Report: what happened at OVIT last week (0728-0801)?
Weekly Report · 08/04/2025 12:06
Weekly Report: what happened at OVIT last week (0721-0725)?
Weekly Report · 07/28/2025 12:07
More
About OVIT
OncoVista Innovative Therapies, Inc. is a biopharmaceutical company. The Company is engaged in developing targeted anticancer therapies by utilizing tumor-associated biomarkers. The Company's product pipeline consists of advanced (Phase II) and early (Phase I) clinical-stage compounds, late preclinical drug candidates and early preclinical leads. The Company's therapeutic strategy is based on targeting the patient's tumors with treatments that will deliver drugs selectively based upon specific biochemical characteristics of the cancer cells comprising the tumor. The Company's products include: Cordycepin (OVI-123) and L-Nucleoside Conjugates (OVI-117). Cordycepin depends upon the presence of a DNA polymerase, known as terminal deoxynucleotidyl transferase (TdT), for its therapeutic activity. OVI-117 is a thymidylate synthase (TS) inhibitor with pharmacological properties, which results in a retention of efficacy and a reduction of toxicity.

Webull offers OncoVista Innovative Therapies Inc stock information, including EXMKT: OVIT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OVIT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OVIT stock methods without spending real money on the virtual paper trading platform.